DAPRIL 5 MG TBL NOB 30

What is the maximum co-payment for DAPRIL?

If the insurance company contributes, the maximum co-payment is 20,81 Kč. The maximum pharmacy price is 32,21 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but the reimbursement conditions (reporting limit) have not been set.

Does DAPRIL have a counted co-payment set?

Yes, the medicine has a counted co-payment of 18,00 Kč. Learn more about the protective limit here.

How much does the insurance company pay for one dispensed reimbursed pack?

11,40 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

The medicine has no indication restriction. Its reimbursement is not conditional on a specific diagnosis or clinical condition.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe DAPRIL?

Prescription is not conditional on a medical specialization.

What is the composition of DAPRIL?

Dihydrát lisinoprilu (5,45 mg), lisinopril (5 mg), mannitol, dihydrát hydrogenfosforečnanu vápenatého, červený oxid železitý, kukuřičný škrob, neznámá látka s kódem 5214, magnesium-stearát. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to DAPRIL?

The medicine belongs to ATC group C09AA03 – LISINOPRIL. Medicines with the same active substance can be found here.

Who manufactures DAPRIL?

Medochemie Ltd., Limassol (CY)

Is the medicine in shortage?

The latest report from the manufacturer is from 17. 3. 2025. Production was terminated with effect from 17. 3. 2025. The manufacturer lists medicines with the following code as a potential substitute: